Autoimmunity through Cytokine-Induced Dendritic Cell Activation

Slides:



Advertisements
Similar presentations
Diagnostic Immunology Topic: Immunological Tolerance Objectives: Define Immunological tolerance Define Immunological tolerance Discuss mechanism of tolerance.
Advertisements

T cell-mediated immunity Chapter 8
DIFFERENTIATION AND MATURATION OF T CELLS IN THE THYMUS.
1. Repetition is good, especially in different contexts. 2. As good students, you are accustomed to mastering “the syllabus.” At least in this course,
The life history of T lymphocytes Precursors mature in the thymus Naïve CD4+ and CD8+ T cells enter the circulation Naïve T cells circulate through lymph.
Lecture #10 Aims Describe T cell maturation and be able to differentiate naïve and effector T cells. Differentiate the development and functions of Th1.
Germline-encoded receptors Gene rearranged receptors: TCR/BCR Ags………. Innate immunity Adaptive immunity B/T cells Pattern recognition Epitope recognition.
MICR 304 Immunology & Serology Lecture 6 NK Cells, Lymphocytes Chapter 1.4 –1.17; 2.30 – 2.33 Lecture 6 NK Cells, Lymphocytes Chapter 1.4 –1.17; 2.30 –
Lecture 6 clinical immunology Cytokines
Chapter 15.  Immunological tolerance is defined as unresponsiveness to an antigen that is induced by previous exposure to that antigen  Antigens that.
DR.Hameed n.mousa Ficms pathology Head of depatment
In acquired immunity, lymphocytes provide specific defenses against infection
Activation of T Lymphocytes
Mechanisms of T Cell Tolerance
CATEGORY: CELLS TH17 CELLS
Autoimmune diseases Ch. 4 p (99 – 159) March 7 /2016 March
Immunology Lecture 4 Development of B and T lymphocytes
Mononuclear phagocytes in Immune Defence
Cell mediated Immunity
CELL-MEDIATED IMMUNITY RAHUL KUMAR LOHANA 2K16/MB/50 INSTITUTE OF MICROBIOLOGY UNIVERSITY OF SINDH, JAMSHORO.
Other Cells of Immune System
Dendritic Cell Immunotherapy for the Treatment of Neoplastic Disease
Figure 2 Cell-mediated disease mechanisms of lupus nephritis
Immunological Tolerance
T Cell Death and Transplantation Tolerance
Immune System Review.
Alan N. Houghton, Hiroshi Uchi, Jedd D. Wolchok  Cancer Cell 
Adaptive Immune System
The body’s defenders.
The Th17 immune response in renal inflammation
by Edward S. Morris, Kelli P. A. MacDonald, and Geoffrey R. Hill
Interfering with baffled B cells at the lupus tollway: Promises, successes, and failed expectations  Namrata Singh, MD, Bharat Kumar, MD, Vijay Aluri,
Pathogenesis of primary biliary cirrhosis
Malaria Vaccine Design: Immunological Considerations
Ana C. Anderson, Nicole Joller, Vijay K. Kuchroo  Immunity 
Figure 3 Effect of sialylated glycoforms on IgG activity
Histamine in the immune regulation of allergic inflammation
The 3 major types of innate and adaptive cell-mediated effector immunity  Francesco Annunziato, PhD, Chiara Romagnani, MD, PhD, Sergio Romagnani, MD  Journal.
Bali Pulendran, Rafi Ahmed  Cell 
Celiac Disease: From Pathogenesis to Novel Therapies
The Incognito Journey of a Regulatory B Cell
Tilo Biedermann, Martin Röcken, José M. Carballido 
Percy A. Knolle, Robert Thimme  Gastroenterology 
In Vivo Role of pDCs in Regulating Adaptive Immunity
Thomas S. Griffith, Thomas A. Ferguson  Immunity 
Designing Vaccines Based on Biology of Human Dendritic Cell Subsets
Role of IgE in autoimmunity
Old Meets New: The Interaction Between Innate and Adaptive Immunity
Immunology Dr. Refif S. Al-Shawk
Immunological Tolerance
Figure 2 Cellular contributions to the development of SLE
Multistep Pathogenesis of Autoimmune Disease
Th1 and Th2 immune responses
Pathogenesis of primary biliary cirrhosis
Janine Bilsborough, Joanne L. Viney  Gastroenterology 
Nat. Rev. Rheumatol. doi: /nrrheum
Autoimmunity: When self-tolerance breaks down
Basophils and mast cells in renal injury
T Cell Activation and proliferation
SLE: the many players involved in systemic autoimmunity and tissue destruction. SLE: the many players involved in systemic autoimmunity and tissue destruction.
The Biology of Intestinal Immunoglobulin A Responses
Vaccines for Lung Cancer
Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell–mediated allergic inflammation  Yong-Jun Liu, MD, PhD  Journal.
Dendritic-Cell-Based Therapeutic Cancer Vaccines
Plasmacytoid Dendritic Cells in Melanoma: Can We Revert Bad into Good?
Jacques Banchereau, Virginia Pascual  Immunity 
Molecular and cellular mechanisms of food allergy and food tolerance
Volume 27, Issue 5, Pages (November 2007)
Cytokines and cytokine receptors involved in type I immunity in tuberculosis. Cytokines and cytokine receptors involved in type I immunity in tuberculosis.
Figure 2 Involvement of plasmacytoid dendritic cells
Presentation transcript:

Autoimmunity through Cytokine-Induced Dendritic Cell Activation Jacques Banchereau, Virginia Pascual, A.Karolina Palucka  Immunity  Volume 20, Issue 5, Pages 539-550 (May 2004) DOI: 10.1016/S1074-7613(04)00108-6

Figure 1 Fate of Autoreactive T Cells Autoreactive thymic escapees are silenced in periphery via immature DCs, which control peripheral tolerance. Excess IFN-αβ induces unabated DC maturation, which leads to activation/expansion of autoreactive T cells. Immunity 2004 20, 539-550DOI: (10.1016/S1074-7613(04)00108-6)

Figure 2 IFN-α as a Pathogenic Factor in SLE High levels of IFN-α in SLE might explain several immunological findings of this disease, including (1) permanent maturation of myeloid DCs resulting in activation rather then silencing of autoreactive T cells and autoantigen presentation from captured apoptotic cells; (2) T lymphopenia (Lin et al., 1998), concomitant with expansion of effector T cells overexpressing granzymes and perforin; and (3) B lymphopenia (Lin et al., 1998), concomitant with the expansion of CD38+ GC-like B cells (Galibert et al., 1996) found in SLE blood and accelerated plasma cell differentiation. Immunity 2004 20, 539-550DOI: (10.1016/S1074-7613(04)00108-6)

Figure 3 Mechanisms of Excess IFN-αβ Virus triggers IFN-αβ secretion that normally is controlled by SOCS1 and/or by TNF. Continued presence of TLR7 or TLR9 ligands, for example, virus, or DNA-anti-DNA immune complexes, sustains IFN-αβ production, which is further supported by deletion of SOCS1 function (through genetic alteration) and/or by TNF blockade via soluble TNF receptors. Immunity 2004 20, 539-550DOI: (10.1016/S1074-7613(04)00108-6)

Figure 4 The Weight of Cytokine Environment on DC Differentiation/Maturation Microbes can induce DC maturation directly via pattern recognition receptors on DCs. Alternatively, other cell types, including stromal cells (epithelial cells, keratinocytes, and fibroblasts), mast cells, plasmacytoid DCs, and NK cells respond to microbes by secreting different cytokines (IFN-α/β, TNF, IFN-γ, IL-4, IL-15, IL-1, etc.). Such cytokines activated DC differentially yielding distinct subsets that induce distinct types of immune responses. Immunity 2004 20, 539-550DOI: (10.1016/S1074-7613(04)00108-6)

Figure 5 Distinct DC Subsets Induce Different Autoimmune Response, Leading to Different Autoimmune Diseases IFN-α/β and TNF will generate distinct DC subsets. These DCs will capture opsonized apoptotic bodies. Distinct proteolytic enzymes expressed by these distinct DC subsets will generate distinct repertoire of peptides leading to a distinct set of MHC peptide complexes and, thus, a distinct antigen-specific lymphocyte repertoire. IFN-DCs will present nuclear antigens eventually leading to generation of anti-dsDNA antibodies typical of SLE. In contrast, TNF-DCs will present Fc fragment of immunoglobulins eventually leading to generation of rheumatoid factor typical of rheumatoid arthritis. Immunity 2004 20, 539-550DOI: (10.1016/S1074-7613(04)00108-6)

Figure 6 The Four Arms of Immune Homeostasis and Disease Immunity is viewed as a dynamic system driven by two sets of opposite vectors, i.e., TNF and IFN-α/β, IL-4 and IFN-γ. The sum of the vectors yields an equilibrium point, which allows protective immunity when vectors are equal. This dynamic system can accommodate a prevalence of either vector. However, when one of the vectors prevails beyond a certain threshold, the equilibrium point moves into a zone of autoimmunity. Thus, when TNF vector prevails, then TNF-mediated autoimmunity will occur, such as arthritis. When IFN-α/β vector prevails, then IFN autoimmunity will occur, including SLE, thyroiditis, and diabetes. The prevalence of IL-4 will drive allergy while IFN-γ will sustain inflammation. The prevalence of one vector may be due to its absolute strengthening due to its increased production or its relative strengthening due to the weakening of the opposite vector. Immunity 2004 20, 539-550DOI: (10.1016/S1074-7613(04)00108-6)